A detailed history of West Hill Financial Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, West Hill Financial Advisors, Inc. holds 2,766 shares of ABBV stock, worth $478,573. This represents 0.12% of its overall portfolio holdings.

Number of Shares
2,766
Previous 2,767 0.04%
Holding current value
$478,573
Previous $474,000 15.19%
% of portfolio
0.12%
Previous 0.12%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$163.84 - $199.33 $163 - $199
-1 Reduced 0.04%
2,766 $546,000
Q1 2024

Apr 24, 2024

SELL
$159.82 - $182.1 $66,165 - $75,389
-414 Reduced 13.01%
2,767 $503,000
Q4 2023

Jan 31, 2024

SELL
$137.6 - $154.97 $16,236 - $18,286
-118 Reduced 3.58%
3,181 $492,000
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $31,928 - $36,961
239 Added 7.81%
3,299 $491,000
Q2 2023

Aug 10, 2023

SELL
$132.51 - $164.9 $9,805 - $12,202
-74 Reduced 2.36%
3,060 $412,000
Q1 2023

May 11, 2023

SELL
$144.61 - $166.54 $78,812 - $90,764
-545 Reduced 14.81%
3,134 $499,000
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $69,984 - $83,930
506 Added 15.95%
3,679 $594,000
Q1 2022

Apr 27, 2022

SELL
$131.98 - $163.75 $5,939 - $7,368
-45 Reduced 1.4%
3,173 $514,000
Q3 2021

Oct 13, 2021

SELL
$106.4 - $120.78 $11,704 - $13,285
-110 Reduced 3.31%
3,218 $347,000
Q1 2021

Oct 13, 2021

SELL
$102.3 - $112.62 $613 - $675
-6 Reduced 0.18%
3,328 $360,000
Q4 2020

Feb 17, 2021

BUY
$80.49 - $108.67 $268,353 - $362,305
3,334 New
3,334 $357,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $306B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track West Hill Financial Advisors, Inc. Portfolio

Follow West Hill Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Hill Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on West Hill Financial Advisors, Inc. with notifications on news.